Serum Nesfatin-1 is Reduced in Type 2 Diabetes Mellitus Patients with Peripheral Arterial Disease

BACKGROUND: Nesfatin-1, recently identified as a satiety regulator, elicits an anti-atherosclerosis effect. Our study was designed to determine whether there is an association between serum nesfatin-1 and the development and severity of peripheral arterial disease (PAD) in patients with type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Shimei, Qu, Wei, Dang, Shuangsuo, Xie, Xuan, Xu, Jing, Wang, Yuhuan, Jing, Aiyu, Zhang, Chunhong, Wang, Junhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396685/
https://www.ncbi.nlm.nih.gov/pubmed/25841171
http://dx.doi.org/10.12659/MSM.892611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396685/
https://www.ncbi.nlm.nih.gov/pubmed/25841171
http://dx.doi.org/10.12659/MSM.892611

Ejemplares similares